Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Leif Bjermer

Showing results (181-190 of 272) with videos related to

Pageof 28
Sort By:
Scientific Reports|July 7, 2016
MSC from fetal and adult lungs possess lung-specific properties compared to bone marrow-derived MSCSara Rolandsson Enes, Annika Andersson Sjöland, Ingrid Skog, et al.
Respiratory Research|December 13, 2017
Indacaterol/glycopyrronium is cost-effective compared to salmeterol/fluticasone in COPD: FLAME-based modelling in a Swedish populationLeif Bjermer, Job F M van Boven, Madlaina Costa-Scharplatz, et al.
Therapeutic Advances in Respiratory Disease|September 30, 2021
A new protocol for exercise testing in COPD; improved prediction algorithm for <i>W</i> and validation of the endurance test in a placebo-controlled double bronchodilator studyEllen Tufvesson, Finn Radner, Anton Simonsen, et al.
Scientific Reports|March 24, 2026
Change in the chondroitin/dermatan structure in distal lung tissue from COPD patientsHani N Alsafadi, Annika Nybom, Darcy Wagner, et al.
Journal of Innate Immunity|May 1, 2015
Collagen VI Is Upregulated in COPD and Serves Both as an Adhesive Target and a Bactericidal Barrier for Moraxella catarrhalisSuado M Abdillahi, Marta Bober, Sara Nordin, et al.
BMJ Open|October 29, 2018
Real-world effectiveness evaluation of budesonide/formoterol Spiromax for the management of asthma and chronic obstructive pulmonary disease in the UKJaco Voorham, Nicolas Roche, Hicham Benhaddi, et al.
Frontiers in Immunology|October 13, 2023
Corrigendum: The pulmonary extracellular matrix is a bactericidal barrier against <i>Haemophilus influenzae</i> in chronic obstructive pulmonary disease (COPD): implications for an <i>in vivo</i> innate host defense function of collagen VISuado M Abdillahi, Ramesh Tati, Sara L Nordin, et al.
Respiratory Research|February 15, 2013
Defective alterations in the collagen network to prostacyclin in COPD lung fibroblastsAnna-Karin Larsson-Callerfelt, Oskar Hallgren, Annika Andersson-Sjöland, et al.
Respiratory Research|January 20, 2018
Chronic obstructive pulmonary disease guidelines in Europe: a look into the futureMarc Miravitlles, Nicolas Roche, João Cardoso, et al.
Frontiers in Immunology|September 21, 2018
The Pulmonary Extracellular Matrix Is a Bactericidal Barrier Against <i>Haemophilus influenzae</i> in Chronic Obstructive Pulmonary Disease (COPD): Implications for an <i>in vivo</i> Innate Host Defense Function of Collagen VISuado M Abdillahi, Ramesh Tati, Sara L Nordin, et al.
Pageof 28

Showing results (181-190 of 272) with videos related to

Sort By:
Pageof 28
Scientific Reports|July 7, 2016
MSC from fetal and adult lungs possess lung-specific properties compared to bone marrow-derived MSCSara Rolandsson Enes, Annika Andersson Sjöland, Ingrid Skog, et al.
Respiratory Research|December 13, 2017
Indacaterol/glycopyrronium is cost-effective compared to salmeterol/fluticasone in COPD: FLAME-based modelling in a Swedish populationLeif Bjermer, Job F M van Boven, Madlaina Costa-Scharplatz, et al.
Therapeutic Advances in Respiratory Disease|September 30, 2021
A new protocol for exercise testing in COPD; improved prediction algorithm for <i>W</i> and validation of the endurance test in a placebo-controlled double bronchodilator studyEllen Tufvesson, Finn Radner, Anton Simonsen, et al.
Scientific Reports|March 24, 2026
Change in the chondroitin/dermatan structure in distal lung tissue from COPD patientsHani N Alsafadi, Annika Nybom, Darcy Wagner, et al.
Journal of Innate Immunity|May 1, 2015
Collagen VI Is Upregulated in COPD and Serves Both as an Adhesive Target and a Bactericidal Barrier for Moraxella catarrhalisSuado M Abdillahi, Marta Bober, Sara Nordin, et al.
BMJ Open|October 29, 2018
Real-world effectiveness evaluation of budesonide/formoterol Spiromax for the management of asthma and chronic obstructive pulmonary disease in the UKJaco Voorham, Nicolas Roche, Hicham Benhaddi, et al.
Frontiers in Immunology|October 13, 2023
Corrigendum: The pulmonary extracellular matrix is a bactericidal barrier against <i>Haemophilus influenzae</i> in chronic obstructive pulmonary disease (COPD): implications for an <i>in vivo</i> innate host defense function of collagen VISuado M Abdillahi, Ramesh Tati, Sara L Nordin, et al.
Respiratory Research|February 15, 2013
Defective alterations in the collagen network to prostacyclin in COPD lung fibroblastsAnna-Karin Larsson-Callerfelt, Oskar Hallgren, Annika Andersson-Sjöland, et al.
Respiratory Research|January 20, 2018
Chronic obstructive pulmonary disease guidelines in Europe: a look into the futureMarc Miravitlles, Nicolas Roche, João Cardoso, et al.
Frontiers in Immunology|September 21, 2018
The Pulmonary Extracellular Matrix Is a Bactericidal Barrier Against <i>Haemophilus influenzae</i> in Chronic Obstructive Pulmonary Disease (COPD): Implications for an <i>in vivo</i> Innate Host Defense Function of Collagen VISuado M Abdillahi, Ramesh Tati, Sara L Nordin, et al.
Pageof 28